ESC Premium Access

Do substrate modification in catheter ablation of atrial fibrillation increase the incidence acute complications: analysis of 10,795 procedures

Topic: Rhythm Control, Catheter Ablation

Congress Presentation

About the speaker

Professor Yuji Murakawa

Mizonokuchi Hospital- Teikyo University School of Medicine, Kawasaki (Japan)
0 follower

9 more presentations in this session

Role of cardioversion in the management of non-valvular atrial fibrillation: insights from the GARFIELD-AF registry

Speaker: Doctor V. Schirripa (Rome, IT)


Cryoballoon versus radiofrequency ablation for atrial fibrillation - a study of outcome and safety based on the ESC-EHRA AF ablation long-term registry and the Swedish catheter ablation registry

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)


Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation: the protective role of antiarrhythmic drug therapy

Speaker: Doctor J. Mesquita (Lisbon, PT)


Long-term outcome of pulmonary vein isolation versus amiodarone therapy in patients with coexistent persistent atrial fibrillation and congestive heart failure

Speaker: Doctor S. Mohanty (Austin, US)


Significance of left atrial appendage isolation in patients with long-standing persistent atrial fibrillation undergoing catheter ablation

Speaker: Doctor S. Mohanty (Austin, US)


Access the full session

Treatment of atrial fibrillation

Speakers: Professor Y. Murakawa, Doctor V. Schirripa, Professor C. Blomstrom-Lundqvist, Doctor J. Mesquita, Doctor S. Mohanty...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by